COSMOS (3349.T, JPX) intraday 09 Jan 2026: JPY 7733.00 ahead of earnings
3349.T stock trades at JPY 7733.00 intraday on 09 Jan 2026, with volume at 707200.00 shares as investors position ahead of COSMOS Pharmaceutical’s Jan 13 earnings. The chain operator’s TTM EPS is 390.78 with a PE of 19.66, and recent quarterly beats and one miss make the upcoming report a market focal point. We assess earnings drivers, valuation, technicals and what the numbers mean for short-term trading on the JPX.
Earnings preview: 3349.T stock and the Jan 13 report
COSMOS Pharmaceutical (3349.T) reports after hours on 13 Jan 2026, and the market is watching same-store sales, gross margin and inventory trends. Recent quarterly results show mixed outcomes: beats on 2025-01-10 (EPS 79.31) and 2025-04-14 (EPS 99.86), but a miss on 2025-07-11 (EPS 108.95 vs est 112.38).
Recent results & guidance: 3349.T stock earnings track
Revenue has been stable with reported figures near JPY 246,332,000,000.00 to JPY 259,122,000,000.00 in recent filings, and management has kept a conservative operating outlook. Analysts will parse margin drivers: COSMOS runs 1,130 stores and inventory turnover and payroll costs were key in prior quarters.
Valuation & financials: 3349.T stock fundamentals
The company trades at a TTM PE of 19.66 and a PB of 2.32, below some healthcare peers but in line with Japanese retail drug chains. Key ratios: current ratio 0.74, debt to equity 0.16, and dividend per share JPY 75.00, signaling modest leverage and steady shareholder returns.
Technical and trading view: 3349.T stock intraday signals
Intraday range sits between JPY 7732.00 low and JPY 7944.00 high with price near the 50-day average JPY 7590.84. Momentum indicators show RSI 45.78 and MACD histogram negative, suggesting neutral-to-cautious short-term bias for traders ahead of earnings.
Meyka grade & forecast: 3349.T stock score and price outlook
Meyka AI rates 3349.T with a score out of 100: 77.22 (B+, BUY). This grade factors in S&P 500 benchmark comparison, sector performance, financial growth, key metrics, and analyst consensus. Meyka AI’s forecast model projects a yearly price of JPY 7235.66, implying -6.43% versus the current JPY 7733.00; forecasts are model-based projections and not guarantees.
Risks and catalysts: 3349.T stock near-term drivers
Catalysts: same-store sales growth, margin improvement from private-label lines, and a clean inventory readout could lift the stock above JPY 8,200.00. Risks: weak consumer spending, margin pressure from promotional activity, and disappointing guidance could push the price toward JPY 7,000.00.
Final Thoughts
COSMOS Pharmaceutical (3349.T) is trading at JPY 7733.00 intraday as the market braces for the Jan 13 earnings report. Our price targets: conservative JPY 7000.00 (down -9.48%), base JPY 8200.00 (up 6.04%), and optimistic JPY 9500.00 (up 22.85%) based on margin recovery and comparable retail multiples. Meyka AI’s model projects JPY 7235.66 for the year, implying -6.43% vs today; forecasts are model-based projections and not guarantees. Investors should weigh COSMOS’s solid balance sheet (debt to equity 0.16) and dividend yield near 0.98% against a tight current ratio 0.74 and mixed recent beats on EPS. For intraday traders on the JPX, watch reaction to guidance and same-store sales — a clean beat could flip technicals bullish, while cautious guidance could widen intraday ranges. This analysis is produced with input from the Meyka AI-powered market analysis platform and is for informational purposes only.
FAQs
When does COSMOS report earnings and why it matters for 3349.T stock?
COSMOS reports after market on 13 Jan 2026. The release matters because revenue, margins and store-level trends drive short-term moves in 3349.T stock and set guidance that traders use to reprice the shares.
What is Meyka AI’s view on 3349.T stock price direction?
Meyka AI’s model projects JPY 7235.66 for the year, implying -6.43% vs current price JPY 7733.00. This is a model projection and not a guarantee; price targets vary with earnings and guidance.
How is COSMOS valued versus peers and what ratios matter for 3349.T stock?
COSMOS trades at PE 19.66 and PB 2.32. Important ratios for 3349.T stock are current ratio 0.74, debt to equity 0.16, and dividend per share JPY 75.00 when comparing retail pharmacy peers.
Disclaimer:
Stock markets involve risks. This content is for informational purposes only. Past performance does not guarantee future results. Meyka AI PTY LTD provides market analysis and data insights, not financial advice. Always conduct your own research and consider consulting a licensed financial advisor.
